Purchases and Sales Made in Q3 2022 in Viridian Therapeutics, Inc.\De (VRDN)
This table provides information about the institutional ownership of Viridian Therapeutics, Inc.\De (VRDN) during Q3 2022. The information is specifically focused on institutions that hold shares of Viridian Therapeutics, Inc.\DE.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Commodore Capital LP
New York, NY |
BUY
|
- |
1.06M+ 64.55% |
$11.3M - $27M
|
2.7M
$64.1M
|
|
|
Nov 14, 2022
Q3 2022
|
Logos Global Management LP
San Francisco, CA |
BUY
|
- |
1MNew |
$10.7M - $25.5M
|
1M
$23.8M
|
|
|
Nov 14, 2022
Q3 2022
|
Ra Capital Management, L.P.
Boston, MA |
BUY
|
- |
880KNew |
$9.42M - $22.4M
|
880K
$20.9M
|
|
|
Nov 14, 2022
Q3 2022
|
Deep Track Capital, LP
Greenwich, CT |
BUY
|
- |
800K+ 68.36% |
$8.56M - $20.4M
|
1.97M
$46.9M
|
|
|
Nov 15, 2022
Q3 2022
|
State Street Corp
Boston, MA |
BUY
|
- |
723K+ 158.98% |
$7.74M - $18.4M
|
1.18M
$28M
|
|
|
Nov 03, 2022
Q3 2022
|
Barclays PLC
London, X0 |
BUY
|
- |
635K+ 3473.39% |
$6.8M - $16.2M
|
654K
$15.6M
|
|
|
Nov 14, 2022
Q3 2022
|
Black Rock Inc.
New York, NY |
BUY
|
- |
559K+ 39.3% |
$5.98M - $14.3M
|
1.98M
$47.2M
|
|
|
Nov 14, 2022
Q3 2022
|
5 Am Venture Management, LLC
San Francisco, CA |
BUY
|
- |
485KNew |
$5.19M - $12.4M
|
485K
$11.5M
|
|
|
Nov 14, 2022
Q3 2022
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
446K+ 31.6% |
$4.77M - $11.4M
|
1.86M
$44.2M
|
|
|
Nov 14, 2022
Q3 2022
|
Cormorant Asset Management, LP
Boston, MA |
BUY
|
- |
433K+ 49.29% |
$4.63M - $11M
|
1.31M
$31.2M
|
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
428K+ 45.94% |
$4.58M - $10.9M
|
1.36M
$32.4M
|
|
|
Nov 09, 2022
Q3 2022
|
Fairmount Funds Management LLC
Philadelphia, PA |
BUY
|
- |
426K+ 45.07% |
$4.55M - $10.9M
|
1.37M
$32.6M
|
|
|
Nov 14, 2022
Q3 2022
|
Kynam Capital Management, LP
Princeton, NJ |
BUY
|
- |
410K+ 69.45% |
$4.39M - $10.5M
|
1M
$23.8M
|
|
|
Nov 14, 2022
Q3 2022
|
Yiheng Capital Management, L.P.
San Francisco, CA |
BUY
|
- |
373KNew |
$3.99M - $9.51M
|
373K
$8.87M
|
|
|
Nov 10, 2022
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
370KNew |
$3.96M - $9.43M
|
370K
$8.8M
|
|
|
Nov 14, 2022
Q3 2022
|
Vivo Capital, LLC
Palo Alto, CA |
BUY
|
- |
360K+ 27.69% |
$3.85M - $9.18M
|
1.66M
$39.5M
|
|
|
Nov 14, 2022
Q3 2022
|
Paradigm Biocapital Advisors LP
New York, NY |
BUY
|
- |
330K+ 25.23% |
$3.53M - $8.41M
|
1.64M
$38.9M
|
|
|
May 15, 2023
Q3 2022
|
Vr Adviser, LLC
New York, NY |
BUY
|
- |
277K+ 14.97% |
$2.97M - $7.07M
|
2.13M
$50.7M
|
|
|
Nov 14, 2022
Q3 2022
|
Vr Adviser, LLC
New York, NY |
BUY
|
- |
277K+ 14.97% |
$2.97M - $7.07M
|
2.13M
$50.7M
|
|
|
Nov 14, 2022
Q3 2022
|
Driehaus Capital Management LLC
Chicago, IL |
BUY
|
- |
271K+ 409.72% |
$2.9M - $6.9M
|
337K
$8.01M
|
|
|
Nov 14, 2022
Q3 2022
|
Fred Alger Management, LLC
New York, NY |
BUY
|
- |
261KNew |
$2.79M - $6.66M
|
261K
$6.21M
|
|
|
Nov 14, 2022
Q3 2022
|
Polar Asset Management Partners Inc.
Toronto, A6 |
BUY
|
- |
251K+ 420.6% |
$2.69M - $6.4M
|
311K
$7.39M
|
|
|
Nov 14, 2022
Q3 2022
|
Perceptive Advisors LLC
New York, NY |
BUY
|
- |
249K+ 25.6% |
$2.66M - $6.34M
|
1.22M
$29M
|
|
|
Nov 14, 2022
Q3 2022
|
Invesco Ltd.
Atlanta, GA |
BUY
|
- |
213K+ 1932.22% |
$2.28M - $5.44M
|
224K
$5.34M
|
|
|
Nov 14, 2022
Q3 2022
|
Balyasny Asset Management LLC
Chicago, IL |
BUY
|
- |
170KNew |
$1.81M - $4.32M
|
170K
$4.03M
|
|
|
Nov 14, 2022
Q3 2022
|
Marshall Wace, LLP
London, X0 |
BUY
|
- |
164K+ 36.84% |
$1.75M - $4.18M
|
609K
$14.5M
|
|
|
Nov 14, 2022
Q3 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
150K+ 33.38% |
$1.61M - $3.83M
|
600K
$14.3M
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
137K+ 497.32% |
$1.47M - $3.5M
|
165K
$3.92M
|
|
|
Nov 14, 2022
Q3 2022
|
Acuta Capital Partners, LLC
Belmont, CA |
BUY
|
- |
129K+ 55.0% |
$1.38M - $3.28M
|
363K
$8.63M
|
|
|
Nov 10, 2022
Q3 2022
|
Exodus Point Capital Management, LP
New York, NY |
BUY
|
- |
109KNew |
$1.17M - $2.78M
|
109K
$2.59M
|
|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
102KNew |
$1.09M - $2.59M
|
102K
$2.42M
|
|
|
Nov 14, 2022
Q3 2022
|
Eam Global Investors LLC
Solana Beach, CA |
BUY
|
- |
78.8KNew |
$843K - $2.01M
|
78.8K
$1.87M
|
|
|
Nov 14, 2022
Q3 2022
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
BUY
|
- |
74.4K+ 347.44% |
$796K - $1.9M
|
95.8K
$2.28M
|
|
|
Nov 14, 2022
Q3 2022
|
Rafferty Asset Management, LLC
New York, NY |
BUY
|
- |
57.8KNew |
$618K - $1.47M
|
57.8K
$1.37M
|
|
|
Oct 27, 2022
Q3 2022
|
Chartwell Investment Partners, LLC
|
BUY
|
- |
57.6KNew |
$616K - $1.47M
|
57.6K
$1.37M
|
|
|
Nov 14, 2022
Q3 2022
|
High Vista Strategies LLC
Boston, MA |
BUY
|
- |
57.3K+ 127.3% |
$613K - $1.46M
|
102K
$2.44M
|
|
|
Nov 14, 2022
Q3 2022
|
Eam Investors, LLC
Solana Beach, CA |
BUY
|
- |
53.7KNew |
$575K - $1.37M
|
53.7K
$1.28M
|
|
|
Nov 14, 2022
Q3 2022
|
Schonfeld Strategic Advisors LLC
New York, NY |
BUY
|
- |
52.6KNew |
$563K - $1.34M
|
52.6K
$1.25M
|
|
|
Nov 10, 2022
Q3 2022
|
Citigroup Inc
|
BUY
|
- |
51.5K+ 2763.63% |
$551K - $1.31M
|
53.4K
$1.27M
|
|
|
Nov 14, 2022
Q3 2022
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
50.9K+ 277.65% |
$545K - $1.3M
|
69.3K
$1.65M
|
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
BUY
|
- |
49.3K+ 379107.69% |
$527K - $1.26M
|
49.3K
$1.17M
|
|
|
Nov 14, 2022
Q3 2022
|
Ubs Oconnor LLC
Chicago, IL |
BUY
|
- |
47.5K+ 138.07% |
$508K - $1.21M
|
81.9K
$1.95M
|
|
|
Nov 14, 2022
Q3 2022
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
45K+ 383.38% |
$481K - $1.15M
|
56.7K
$1.35M
|
|
|
Nov 14, 2022
Q3 2022
|
Weiss Multi Strategy Advisers LLC
New York, NY |
BUY
|
- |
45K+ 179.56% |
$481K - $1.15M
|
70K
$1.67M
|
|
|
Nov 04, 2022
Q3 2022
|
Russell Investments Group, Ltd.
|
BUY
|
- |
44.8KNew |
$479K - $1.14M
|
44.8K
$1.07M
|
|
|
Nov 14, 2022
Q3 2022
|
Nuveen Asset Management, LLC
Chicago, IL |
BUY
|
- |
43.8K+ 74.4% |
$469K - $1.12M
|
103K
$2.44M
|
|
|
Nov 08, 2022
Q3 2022
|
Alpha Centric Advisors LLC
San Juan, PR |
BUY
|
- |
35.5KNew |
$380K - $905K
|
35.5K
$845K
|
|
|
Nov 14, 2022
Q3 2022
|
Parkman Healthcare Partners LLC
Stamford, CT |
BUY
|
- |
35.4KNew |
$378K - $902K
|
35.4K
$841K
|
|
|
Nov 08, 2023
Q3 2022
|
Eversept Partners, LP
New York, NY |
BUY
|
- |
32.8K+ 7.36% |
$351K - $836K
|
478K
$11.4M
|
|
|
Nov 14, 2022
Q3 2022
|
Eversept Partners, LP
New York, NY |
BUY
|
- |
32.8K+ 7.36% |
$351K - $836K
|
478K
$11.4M
|